Back to search

Belgium· BE-AMP-SAM662256-00

Myatorlip 10 mg - 10 mg

A atorvastatin and ezetimibe product containing ezetimibe, registered in Belgium by Viatris GX. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMyatorlip 10 mg - 10 mgATCC10BA05REGISTER NO.BE-AMP-SAM662256-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Atorvastatin and ezetimibe is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA05 (atorvastatin and ezetimibe), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Atorvastatin and ezetimibe · ATC C10BA05

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ezetimibe
Manufacturer
Viatris GX
Country
Belgium (BE)
ATC code
C10BA05
ATC class
Atorvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    4826707
    EUR 46.89
  • be_apb
    7741150

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for atorvastatin and ezetimibe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atorvastatin and ezetimibe · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb47c1ef-9933-4351-8969-69fab817d8d8
GET /v1/drugs/fb47c1ef-9933-4351-8969-69fab817d8d8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Myatorlip 10 mg - 10 mg",
  "name_fr": "Myatorlip 10 mg - 10 mg",
  "name_nl": "Myatorlip 10 mg - 10 mg",
  "amp_code": "SAM662256-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.8250",
    "10.8250",
    "10.0000",
    "10.0000",
    "126.1500",
    "26.6000",
    "3.8500",
    "0.4000"
  ],
  "pack_count": 4,
  "substances": [
    "Ezetimibe",
    "Atorvastatin Calcium Trihydrate",
    "Atorvastatin",
    "Lactose Monohydrate",
    "Sodium Laurilsulfate",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Atorvastatin and Ezetimibe",
  "authorisation_numbers": [
    "BE662256"
  ]
}

See everything about atorvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.